Landscape Capital Management’s Context Therapeutics CNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$72.5K Buy
+241,312
New +$119K 0.01% 574
2025
Q2
– Sell
-41,216
Closed -$25.2K – 679
2025
Q1
$25.2K Sell
41,216
-48,784
-54% -$42.5K ﹤0.01% 601
2024
Q4
$94.5K Buy
+90,000
New +$156K 0.01% 662

Other funds holding CNTX

Landscape Capital Management's CNTX Position: Q3 2026 in Review

Landscape Capital Management opened a new position in Context Therapeutics (CNTX) in Q3 2026: 241,312 shares worth $72.5K. The stake represents 0.01% of the portfolio and ranks #574 among its holdings. This is a return to the name: Landscape Capital Management previously reported a position in CNTX as recently as Q1 2025.

Landscape Capital Management first reported a position in CNTX in Q4 2024 and has held it in 3 quarters since. The position peaked at $94.5K in Q4 2024. 87 funds tracked by Wall St. Rank hold CNTX as of Q3 2026.

  • Landscape Capital Management held 241,312 shares of Context Therapeutics worth $72.5K as of Q3 2026.
  • Context Therapeutics was a new Landscape Capital Management position in Q3 2026.
  • Context Therapeutics made up 0.01% of Landscape Capital Management's portfolio in Q3 2026, its #574 holding.
  • Landscape Capital Management first reported a position in Context Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Landscape Capital Management's Context Therapeutics position peaked at $94.5K in Q4 2024.
  • 87 funds tracked by Wall St. Rank held Context Therapeutics as of Q3 2026.

Based on Landscape Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.